Skip to main content
Medical Hypothesis, Discovery and Innovation in Ophthalmology logoLink to Medical Hypothesis, Discovery and Innovation in Ophthalmology
letter
. 2012 Spring;1(1):18.

Glycosylation End-product Formation in Retinal Membranes, an Energy Alteration Injury

Viroj Wiwanitkit 1
PMCID: PMC3939741  PMID: 24600613

Dear Editor,

Poorly controlled diabetes mellitus can lead to blindness due to severe proliferative diabetic retinopathy. The pathophysiology of retinal involvement is important in diabetic retinopathy, with stress-induced cellular ion change and oxidation generally proposed to be the underlying mechanism [12]. Based on the concept of nanomedicine, it has been proven that there is no alteration in flux crossing the retina membrane in diabetes mellitus, so this cannot be the cause of retinopathy [3]. The author hereby proposed a new theory that there must also be an underlying problem in the cell directly. Indeed, retina cells also contain the protein, and this could be the attack point for hyperglycaemic bombardment. Applying the concept of energy fluctuation due to a high blood glucose-induced glycosylation process [4], the pathology of the retina might be explained. Indeed, the discovery of glycosylation processes in retinal cells has just been reported [5], which confirms the opinion of the energy fluctuation-induced retinal problems in poorly controlled diabetic cases [4]. This hypothesis could be justified by further basic clinical investigations.

DISCLOSURE

The authors report no conflicts of interest in this work.

References

  • 1.Kowluru RA. Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1581–87. doi: 10.1089/ars.2005.7.1581. PMID: 16356121. [DOI] [PubMed] [Google Scholar]
  • 2.Santilli F, Cipollone F, Mezzetti A, Chiarelli F. The role of nitric oxide in the development of diabetic angiopathy. Horm Metab Res. 2004 May;36(5):319–35. doi: 10.1055/s-2004-814489. PMID: 15156413. [DOI] [PubMed] [Google Scholar]
  • 3.Wiwanitkit V. Oxidation flux change in diabetic retinopathy: does it exist or not. Diabetol Croat. 2007;36(3):55–57. [Google Scholar]
  • 4.Wiwanitkit V, House VWW, Bangkhae BT. Energy fluctuation in glycosylated end product formation: a new explanation on pathogenesis for complication in poorly controlled diabetic patient. Adv Lab Med Int. 2011;1(2):6–10. [Google Scholar]
  • 5.Chen CL, Liang CM, Chen YH, Tai MC, Lu DW, Chen JT. Glucosamine modulates TNF-α-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2012 Apr;53(4):2281–91. doi: 10.1167/iovs.11-9291. PMID: 22427561. [DOI] [PubMed] [Google Scholar]

Articles from Medical Hypothesis, Discovery and Innovation in Ophthalmology are provided here courtesy of International Virtual Ophthalmic Research Center

RESOURCES